These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 14535984)
21. Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis. Wu W; Liu X; Peng X; Xue R; Ji L; Shen X; Chen S; Gu J; Zhang S Biochem Biophys Res Commun; 2014 May; 448(1):50-5. PubMed ID: 24747563 [TBL] [Abstract][Full Text] [Related]
23. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Ip E; Farrell GC; Robertson G; Hall P; Kirsch R; Leclercq I Hepatology; 2003 Jul; 38(1):123-32. PubMed ID: 12829994 [TBL] [Abstract][Full Text] [Related]
24. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice. Min AK; Kim MK; Kim HS; Seo HY; Lee KU; Kim JG; Park KG; Lee IK Life Sci; 2012 Jan; 90(5-6):200-5. PubMed ID: 22154902 [TBL] [Abstract][Full Text] [Related]
25. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Sahai A; Malladi P; Melin-Aldana H; Green RM; Whitington PF Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174 [TBL] [Abstract][Full Text] [Related]
26. Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model. Veteläinen R; van Vliet A; van Gulik TM J Gastroenterol Hepatol; 2007 Sep; 22(9):1526-33. PubMed ID: 17716355 [TBL] [Abstract][Full Text] [Related]
27. Treatment with geraniol ameliorates methionine-choline-deficient diet-induced non-alcoholic steatohepatitis in rats. Chen J; Fan X; Zhou L; Gao X J Gastroenterol Hepatol; 2016 Jul; 31(7):1357-65. PubMed ID: 26695085 [TBL] [Abstract][Full Text] [Related]
28. Quantitative trait loci analysis of mice administered the methionine-choline deficient dietary model of experimental steatohepatitis. Rangnekar AS; Lammert F; Igolnikov A; Green RM Liver Int; 2006 Oct; 26(8):1000-5. PubMed ID: 16953841 [TBL] [Abstract][Full Text] [Related]
29. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis. Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180 [TBL] [Abstract][Full Text] [Related]
30. Glycine alleviates liver injury induced by deficiency in methionine and or choline in rats. Barakat HA; Hamza AH Eur Rev Med Pharmacol Sci; 2012 Jun; 16(6):728-36. PubMed ID: 22913202 [TBL] [Abstract][Full Text] [Related]
31. Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice. Yoshida T; Akiba J; Matsui T; Nakamura K; Hisamoto T; Abe M; Ikezono Y; Wada F; Iwamoto H; Nakamura T; Koga H; Yamagishi SI; Torimura T Dig Dis Sci; 2017 Jun; 62(6):1527-1536. PubMed ID: 28365916 [TBL] [Abstract][Full Text] [Related]
32. Modulatory role of Co-enzyme Q10 on methionine and choline deficient diet-induced non-alcoholic steatohepatitis (NASH) in albino rats. Saleh DO; Ahmed RF; Amin MM Appl Physiol Nutr Metab; 2017 Mar; 42(3):243-249. PubMed ID: 28177750 [TBL] [Abstract][Full Text] [Related]
34. Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis. Pickens MK; Yan JS; Ng RK; Ogata H; Grenert JP; Beysen C; Turner SM; Maher JJ J Lipid Res; 2009 Oct; 50(10):2072-82. PubMed ID: 19295183 [TBL] [Abstract][Full Text] [Related]
35. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. McCuskey RS; Ito Y; Robertson GR; McCuskey MK; Perry M; Farrell GC Hepatology; 2004 Aug; 40(2):386-93. PubMed ID: 15368443 [TBL] [Abstract][Full Text] [Related]
36. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis. Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126 [TBL] [Abstract][Full Text] [Related]
37. JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Schattenberg JM; Singh R; Wang Y; Lefkowitch JH; Rigoli RM; Scherer PE; Czaja MJ Hepatology; 2006 Jan; 43(1):163-72. PubMed ID: 16374858 [TBL] [Abstract][Full Text] [Related]
38. [The role of Fas mutation on non-alcoholic steatohepatitis in mice]. Su SS; Han F; Wang RQ; Ren WG; Wu WJ; Kong LB; Zhao SX; Nan YM Zhonghua Gan Zang Bing Za Zhi; 2011 Sep; 19(9):653-7. PubMed ID: 22152378 [TBL] [Abstract][Full Text] [Related]
39. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis. Salamone F; Galvano F; Cappello F; Mangiameli A; Barbagallo I; Li Volti G Transl Res; 2012 Jun; 159(6):477-86. PubMed ID: 22633099 [TBL] [Abstract][Full Text] [Related]
40. Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis. Zhang S; Wang J; Liu Q; Harnish DC J Hepatol; 2009 Aug; 51(2):380-8. PubMed ID: 19501927 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]